FR2497098B1 - Composition polymere servant a proteger une partie lesee de la muqueuse orale - Google Patents

Composition polymere servant a proteger une partie lesee de la muqueuse orale

Info

Publication number
FR2497098B1
FR2497098B1 FR8124423A FR8124423A FR2497098B1 FR 2497098 B1 FR2497098 B1 FR 2497098B1 FR 8124423 A FR8124423 A FR 8124423A FR 8124423 A FR8124423 A FR 8124423A FR 2497098 B1 FR2497098 B1 FR 2497098B1
Authority
FR
France
Prior art keywords
protecting
polymer composition
oral mucosa
injured part
injured
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR8124423A
Other languages
English (en)
Other versions
FR2497098A1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Teijin Ltd
Original Assignee
Teijin Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Teijin Ltd filed Critical Teijin Ltd
Publication of FR2497098A1 publication Critical patent/FR2497098A1/fr
Application granted granted Critical
Publication of FR2497098B1 publication Critical patent/FR2497098B1/fr
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
    • A61L15/24—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/765—Polymers containing oxygen
    • A61K31/78—Polymers containing oxygen of acrylic acid or derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
    • A61L15/28—Polysaccharides or their derivatives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Materials For Medical Uses (AREA)
  • Medicinal Preparation (AREA)
FR8124423A 1980-12-29 1981-12-29 Composition polymere servant a proteger une partie lesee de la muqueuse orale Expired FR2497098B1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP55185294A JPS57110254A (en) 1980-12-29 1980-12-29 Coating agent of injured membrane part of oral cavity

Publications (2)

Publication Number Publication Date
FR2497098A1 FR2497098A1 (fr) 1982-07-02
FR2497098B1 true FR2497098B1 (fr) 1985-08-09

Family

ID=16168334

Family Applications (1)

Application Number Title Priority Date Filing Date
FR8124423A Expired FR2497098B1 (fr) 1980-12-29 1981-12-29 Composition polymere servant a proteger une partie lesee de la muqueuse orale

Country Status (4)

Country Link
US (1) US4715369A (fr)
JP (1) JPS57110254A (fr)
FR (1) FR2497098B1 (fr)
IT (1) IT1172196B (fr)

Families Citing this family (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0200508B1 (fr) * 1985-04-27 1991-10-02 Nitto Denko Corporation Emplâtres adhésifs et préparations pharmaceutiques pour la cavité buccale
US4786503A (en) * 1987-04-06 1988-11-22 Alza Corporation Dosage form comprising parallel lamine
US4820506A (en) * 1987-05-01 1989-04-11 Research Foundation, State University Of New York Salivary stimulant
US4938763B1 (en) * 1988-10-03 1995-07-04 Atrix Lab Inc Biodegradable in-situ forming implants and method of producing the same
US5702716A (en) * 1988-10-03 1997-12-30 Atrix Laboratories, Inc. Polymeric compositions useful as controlled release implants
US5336210A (en) * 1989-02-28 1994-08-09 Teijin Limited Plaster agent
WO1990009784A1 (fr) 1989-02-28 1990-09-07 Teijin Limited Cataplasme et composition pour celui-ci
US5487897A (en) * 1989-07-24 1996-01-30 Atrix Laboratories, Inc. Biodegradable implant precursor
USRE37950E1 (en) 1990-04-24 2002-12-31 Atrix Laboratories Biogradable in-situ forming implants and methods of producing the same
IT1250421B (it) * 1991-05-30 1995-04-07 Recordati Chem Pharm Composizione farmaceutica a rilascio controllato con proprieta' bio-adesive.
AU2605592A (en) * 1991-10-15 1993-04-22 Atrix Laboratories, Inc. Polymeric compositions useful as controlled release implants
US5296472A (en) * 1991-12-05 1994-03-22 Vyrex Corporation Methods for delipidation of skin and cerumen removal
US5571533A (en) * 1992-02-07 1996-11-05 Recordati, S.A., Chemical And Pharmaceutical Company Controlled-release mucoadhesive pharmaceutical composition for the oral administration of furosemide
US5384333A (en) * 1992-03-17 1995-01-24 University Of Miami Biodegradable injectable drug delivery polymer
US5681873A (en) * 1993-10-14 1997-10-28 Atrix Laboratories, Inc. Biodegradable polymeric composition
US5800832A (en) * 1996-10-18 1998-09-01 Virotex Corporation Bioerodable film for delivery of pharmaceutical compounds to mucosal surfaces
WO1998022097A2 (fr) * 1996-11-20 1998-05-28 Bio Advances, Llc Composition d'une matrice a liberation controlee utilisant un melange d'acide poly(acrylique) et d'un polymere ou d'un monomere polaire
US20050048102A1 (en) * 1997-10-16 2005-03-03 Virotex Corporation Pharmaceutical carrier device suitable for delivery of pharmaceutical compounds to mucosal surfaces
US6660776B1 (en) * 1998-01-15 2003-12-09 Pellom McDaniels, III Composition and method for lubricating and protecting the oral cavity using flavored petroleum jelly
US7128927B1 (en) 1998-04-14 2006-10-31 Qlt Usa, Inc. Emulsions for in-situ delivery systems
US8226598B2 (en) 1999-09-24 2012-07-24 Tolmar Therapeutics, Inc. Coupling syringe system and methods for obtaining a mixed composition
US7803392B2 (en) 2000-12-27 2010-09-28 University Of Kentucky Research Foundation pH-Sensitive mucoadhesive film-forming gels and wax-film composites suitable for topical and mucosal delivery of molecules
US20060073174A1 (en) * 2001-08-16 2006-04-06 Access Pharmaceuticals, Inc. Adherent and erodible film to treat a moist surface of a body tissue
US6585997B2 (en) 2001-08-16 2003-07-01 Access Pharmaceuticals, Inc. Mucoadhesive erodible drug delivery device for controlled administration of pharmaceuticals and other active compounds
US20030167556A1 (en) * 2002-03-05 2003-09-11 Consumers Choice Systems, Inc. Methods and devices for transdermal delivery of anti-aging compounds for treatment and prevention of facial or neck skin aging
US20060210614A1 (en) * 2003-12-26 2006-09-21 Nastech Pharmaceutical Company Inc. Method of treatment of a metabolic disease using intranasal administration of exendin peptide
US20050143303A1 (en) * 2003-12-26 2005-06-30 Nastech Pharmaceutical Company Inc. Intranasal administration of glucose-regulating peptides
US20060074025A1 (en) * 2003-12-26 2006-04-06 Nastech Pharmaceutical Company Inc. Therapeutic formulations for transmucosal administration that increase glucagon-like peptide-1 bioavailability
US20080318837A1 (en) * 2003-12-26 2008-12-25 Nastech Pharmaceutical Company Inc. Pharmaceutical Formation For Increased Epithelial Permeability of Glucose-Regulating Peptide
US20060057165A1 (en) * 2004-09-10 2006-03-16 Dimitrios Dimitrakoudis Clostridium botulinum toxin formulation and method for reducing weight
US20080318861A1 (en) * 2005-12-08 2008-12-25 Nastech Pharmaceutical Company Inc. Mucosal Delivery of Stabilized Formulations of Exendin
EP2054031B1 (fr) 2006-07-21 2016-04-06 BioDelivery Sciences International, Inc. Dispositifs d'administration transmuqueuse avec absorption accrue
WO2010006612A2 (fr) * 2008-06-30 2010-01-21 Coloplast A/S Timbre pour aphte
US8207264B2 (en) 2008-07-11 2012-06-26 Tyco Healthcare Group Lp Functionalized inclusion complexes as crosslinkers
US8701671B2 (en) 2011-02-04 2014-04-22 Joseph E. Kovarik Non-surgical method and system for reducing snoring
US9549842B2 (en) 2011-02-04 2017-01-24 Joseph E. Kovarik Buccal bioadhesive strip and method of treating snoring and sleep apnea
US11998479B2 (en) 2011-02-04 2024-06-04 Seed Health, Inc. Method and system for addressing adverse effects on the oral microbiome and restoring gingival health caused by sodium lauryl sulphate exposure
US11951140B2 (en) 2011-02-04 2024-04-09 Seed Health, Inc. Modulation of an individual's gut microbiome to address osteoporosis and bone disease
US11951139B2 (en) 2015-11-30 2024-04-09 Seed Health, Inc. Method and system for reducing the likelihood of osteoporosis
US11844720B2 (en) 2011-02-04 2023-12-19 Seed Health, Inc. Method and system to reduce the likelihood of dental caries and halitosis
WO2013026064A1 (fr) 2011-08-18 2013-02-21 Biodelivery Sciences International, Inc. Dispositifs mucoadhésifs anti-abus destinés à administrer de la buprénorphine
US9901539B2 (en) 2011-12-21 2018-02-27 Biodelivery Sciences International, Inc. Transmucosal drug delivery devices for use in chronic pain relief
JP2013234173A (ja) * 2012-04-09 2013-11-21 Daiichi Sankyo Healthcare Co Ltd 口腔用半固形剤
US11826388B2 (en) 2013-12-20 2023-11-28 Seed Health, Inc. Topical application of Lactobacillus crispatus to ameliorate barrier damage and inflammation
US12005085B2 (en) 2013-12-20 2024-06-11 Seed Health, Inc. Probiotic method and composition for maintaining a healthy vaginal microbiome
US11833177B2 (en) 2013-12-20 2023-12-05 Seed Health, Inc. Probiotic to enhance an individual's skin microbiome
US11839632B2 (en) 2013-12-20 2023-12-12 Seed Health, Inc. Topical application of CRISPR-modified bacteria to treat acne vulgaris
US11969445B2 (en) 2013-12-20 2024-04-30 Seed Health, Inc. Probiotic composition and method for controlling excess weight, obesity, NAFLD and NASH
US11998574B2 (en) 2013-12-20 2024-06-04 Seed Health, Inc. Method and system for modulating an individual's skin microbiome
US11980643B2 (en) 2013-12-20 2024-05-14 Seed Health, Inc. Method and system to modify an individual's gut-brain axis to provide neurocognitive protection

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS587605B2 (ja) * 1977-09-08 1983-02-10 帝人株式会社 徐放性製剤およびその製造法
JPS5562012A (en) * 1978-11-06 1980-05-10 Teijin Ltd Slow-releasing preparation
GB2042888B (en) * 1979-03-05 1983-09-28 Teijin Ltd Preparation for administration to the mucosa of the oral or nasal cavity
JPS55118414A (en) * 1979-03-05 1980-09-11 Teijin Ltd Prolonged release drug and its preparation

Also Published As

Publication number Publication date
JPS62707B2 (fr) 1987-01-09
IT8150017A0 (it) 1981-12-28
FR2497098A1 (fr) 1982-07-02
JPS57110254A (en) 1982-07-09
US4715369A (en) 1987-12-29
IT1172196B (it) 1987-06-18

Similar Documents

Publication Publication Date Title
FR2497098B1 (fr) Composition polymere servant a proteger une partie lesee de la muqueuse orale
FR2497515B1 (fr) Composition de polymere
ES544252A0 (es) Procedimiento de polimerizacion de composiciones fotopolimerizables.
MC1550A1 (fr) Forme de dosage orale
ES527776A0 (es) Procedimiento de preparacion de derivados de 1,4-dihidropiridinas.
ES523039A0 (es) "un procedimiento para la preparacion de derivados del indol"
ES514146A0 (es) "aparato cancelador de fugas de electrocirugia".
IT8222608A0 (it) Procedimento per l'espossidazione di composti olefinici.
NO158461C (no) Analogifremgangsmaate for fremstilling av fenyl-piperidin-propanol-derivater.
DK331387A (da) Praeparat til forhindring af metastase
ES512087A0 (es) "procedimiento de preparacion de organopolisiloxanos de peso molecular elevado".
ES2022686B3 (es) Protesis total de la rodilla.
SE8300912L (sv) Kompositioner for behandling av glaukom
ES513138A0 (es) "procedimiento de preparacion de compuestos del tipo arilbencensulfonamida".
OA07525A (fr) Dérivés d'acides-animés, leur préparation et utilisation ainsi que les compositions contenant ces dérivés.
DE3363065D1 (de) Primer compositions
ES499299A0 (es) Procedimiento de preparacion de derivados de la trimetoxi- 3,4,5 cinamoilpiperacina
ES511220A0 (es) "procedimiento de preparacion de nuevos derivados 4-aminoetoxi-5-isopropil-2-metil".
ES515227A0 (es) "procedimiento para la preparacion de composiciones poliolefinicas autoextinguentes".
ES515751A0 (es) "un procedimiento por analogia para la preparacion de derivados de espiro-oxindol-oxazolidindiona".
NO164959C (no) Fremgangsmaate for fremstilling av en proteseanordning.
ES511806A0 (es) "procedimiento para la preparacion de composiciones poliolefinicas autoextinguibles".
NO834509L (no) Fremgangsmaate til fremstilling av 1,2-dikloretan
ES512921A0 (es) "procedimiento de preparacion de derivados de etanolamina".
FI821971A0 (fi) Anordning foer att oeppna den tilltaeppta rejektaendan i en centrifugalrenare